Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilar Firms Main Beneficiaries Of Korea R&D Cost Accounting Changes?
Sep 25 2018
•
By
Jung Won Shin
New Korean Guidelines For R&D Cost Related Accounting • Source: Shutterstock
More from South Korea
More from Focus On Asia